Learn More
BACKGROUND The aim of this study is to determine the level of serum cytokeratin19 fragment (cyfra21-1) in patients with benign or malignant pleural effusion and evaluation the sensitivity and specificity of this tumor marker. METHOD #ENTITYSTARTX00026; MATERIAL We prospectively evaluated 98 patients (39 malignant, 54 benign and the results were(More)
  • 1